Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aimee, Kreimer"'
Autor:
Syed Rakin Ahmed, Brian Befano, Andreanne Lemay, Didem Egemen, Ana Cecilia Rodriguez, Sandeep Angara, Kanan Desai, Jose Jeronimo, Sameer Antani, Nicole Campos, Federica Inturrisi, Rebecca Perkins, Aimee Kreimer, Nicolas Wentzensen, Rolando Herrero, Marta del Pino, Wim Quint, Silvia de Sanjose, Mark Schiffman, Jayashree Kalpathy-Cramer
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-18 (2023)
Abstract Cervical cancer is a leading cause of cancer mortality, with approximately 90% of the 250,000 deaths per year occurring in low- and middle-income countries (LMIC). Secondary prevention with cervical screening involves detecting and treating
Externí odkaz:
https://doaj.org/article/5b8bb423fd0943a49499624df87224c8
Autor:
Ligia A. Pinto, Allan Hildesheim, Leen-Jan van Doorn, Wim Quint, Gloriana Shelton, Troy Kemp, Rolando Herrero, Ana C. Rodriguez, Mark Schiffman, Sholom Wacholder, Douglas R. Lowy, Paula Gonzalez, John T. Schiller, Aimee Kreimer, Yuanji Pan, Carolina Porras, Mahboobeh Safaeian
The Costa Rica HPV16/18 Vaccine Trial (CVT) showed that four-year vaccine efficacy against 12-month HPV16/18 persistent infection was similarly high among women who received one, two, or the recommended three doses of the bivalent HPV16/18 L1 virus-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6af7092ee4d86245d1f513994d6d6976
https://doi.org/10.1158/1940-6207.c.6544847
https://doi.org/10.1158/1940-6207.c.6544847
Autor:
Ligia A. Pinto, Allan Hildesheim, Leen-Jan van Doorn, Wim Quint, Gloriana Shelton, Troy Kemp, Rolando Herrero, Ana C. Rodriguez, Mark Schiffman, Sholom Wacholder, Douglas R. Lowy, Paula Gonzalez, John T. Schiller, Aimee Kreimer, Yuanji Pan, Carolina Porras, Mahboobeh Safaeian
Fig. S1A: Individual HPV16 kinetics among the 1 dose group. Fig. S1B: Individual HPV18 kinetics among the 1 dose group. Fig. S1C: Individual HPV16 kinetics among the 2-dose(0/1) group. Fig. S1D: Individual HPV18 kinetics among the 2-dose(0/1) group.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::077d6739fe2e4b56e5a3696573d5e85b
https://doi.org/10.1158/1940-6207.22525667
https://doi.org/10.1158/1940-6207.22525667
Autor:
Syed Rakin Ahmed, Brian Befano, Andreanne Lemay, Didem Egemen, Ana Cecilia Rodriguez, Sandeep Angara, Kanan Desai, Jose Jeronimo, Sameer Antani, Nicole Campos, Federica Inturrisi, Rebecca Perkins, Aimee Kreimer, Nicolas Wentzensen, Rolando Herrero, Marta del Pino, Wim Quint, Silvia de Sanjose, Mark Schiffman, Jayashree Kalpathy-Cramer
Cervical cancer is a leading cause of cancer mortality, with approximately 90% of the 250,000 deaths per year occurring in low- and middle-income countries (LMIC). Secondary prevention with cervical screening involves detecting and treating precursor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::283f8683a659f34d5f97a6b344c71f21
https://doi.org/10.21203/rs.3.rs-2389404/v1
https://doi.org/10.21203/rs.3.rs-2389404/v1
Autor:
Mahboobeh, Safaeian, Carolina, Porras, Yuanji, Pan, Aimee, Kreimer, John T, Schiller, Paula, Gonzalez, Douglas R, Lowy, Sholom, Wacholder, Mark, Schiffman, Ana C, Rodriguez, Rolando, Herrero, Troy, Kemp, Gloriana, Shelton, Wim, Quint, Leen-Jan, van Doorn, Allan, Hildesheim, Ligia A, Pinto
Publikováno v:
Cancer Prev Res (Phila)
The Costa Rica HPV16/18 Vaccine Trial (CVT) showed that four-year vaccine efficacy against 12-month HPV16/18 persistent infection was similarly high among women who received one, two, or the recommended three doses of the bivalent HPV16/18 L1 virus-l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cb35a08f9ccf5364aac1f0ca4558ff9
https://pubmed.ncbi.nlm.nih.gov/26744450
https://pubmed.ncbi.nlm.nih.gov/26744450